Home > Insider Trading > Filing (0001371285-21-000292)

Filing Details

Accession Number:: 0001371285-21-000292
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-15 20:03:02
Reporting Period:: 2021-11-11

Accepted Time:: 2021-11-15 20:03:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1371285	Trupanion Inc.	TRUP	Hospital & Medical Service Plans (6324)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1611679	Darryl Rawlings	C/O Trupanion, Inc. 6100 4Th Avenue South, Suite 200 Seattle WA 98108	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-11-11	100	$120.80	967,122	No	4	S	Indirect	By Kuyashii Primary Equities LLC
Common Stock	Disposition	2021-11-11	518	$122.44	966,604	No	4	S	Indirect	By Kuyashii Primary Equities LLC
Common Stock	Disposition	2021-11-11	2,082	$123.53	964,522	No	4	S	Indirect	By Kuyashii Primary Equities LLC
Common Stock	Disposition	2021-11-11	1,300	$124.30	963,222	No	4	S	Indirect	By Kuyashii Primary Equities LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Kuyashii Primary Equities LLC
No	4	S	Indirect	By Kuyashii Primary Equities LLC
No	4	S	Indirect	By Kuyashii Primary Equities LLC
No	4	S	Indirect	By Kuyashii Primary Equities LLC

Footnotes

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by Kuyashii Primary Equities LLC. a limited liability company indirectly, wholly-owned by the reporting person and reporting person's spouse, on November 3, 2020, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.96 to $122.96 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.99 to $123.93 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.01 to $124.86 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.